JP2010195714A5 - - Google Patents

Download PDF

Info

Publication number
JP2010195714A5
JP2010195714A5 JP2009042671A JP2009042671A JP2010195714A5 JP 2010195714 A5 JP2010195714 A5 JP 2010195714A5 JP 2009042671 A JP2009042671 A JP 2009042671A JP 2009042671 A JP2009042671 A JP 2009042671A JP 2010195714 A5 JP2010195714 A5 JP 2010195714A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
substance
derivative
composition according
hyp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009042671A
Other languages
English (en)
Japanese (ja)
Other versions
JP5560570B2 (ja
JP2010195714A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2009042671A priority Critical patent/JP5560570B2/ja
Priority claimed from JP2009042671A external-priority patent/JP5560570B2/ja
Publication of JP2010195714A publication Critical patent/JP2010195714A/ja
Publication of JP2010195714A5 publication Critical patent/JP2010195714A5/ja
Application granted granted Critical
Publication of JP5560570B2 publication Critical patent/JP5560570B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009042671A 2009-02-25 2009-02-25 創傷治療用医薬組成物 Expired - Fee Related JP5560570B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009042671A JP5560570B2 (ja) 2009-02-25 2009-02-25 創傷治療用医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009042671A JP5560570B2 (ja) 2009-02-25 2009-02-25 創傷治療用医薬組成物

Publications (3)

Publication Number Publication Date
JP2010195714A JP2010195714A (ja) 2010-09-09
JP2010195714A5 true JP2010195714A5 (enExample) 2012-01-05
JP5560570B2 JP5560570B2 (ja) 2014-07-30

Family

ID=42820835

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009042671A Expired - Fee Related JP5560570B2 (ja) 2009-02-25 2009-02-25 創傷治療用医薬組成物

Country Status (1)

Country Link
JP (1) JP5560570B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5459826B2 (ja) * 2009-03-03 2014-04-02 林兼産業株式会社 皮膚線維芽細胞におけるエラスチン産生促進剤及び血管内皮細胞の増殖促進剤
JP6709440B2 (ja) * 2018-06-08 2020-06-17 学校法人福岡大学 肥厚性瘢痕の形成抑制用組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868156A (en) * 1986-02-28 1989-09-19 Bio-Tech A/S Pharmaceutical preparation containing a dipeptide with cell growth regulating effect
GB2321191B (en) * 1997-01-17 2000-09-27 Johnson & Johnson Medical Peptides for use in wound treatment
JP2002255847A (ja) * 2001-02-26 2002-09-11 Miyagi Kagaku Kogyo Kk コラーゲン産生促進剤、それを含む機能性食品および医薬品
JP2003137807A (ja) * 2001-11-01 2003-05-14 Miyagi Kagaku Kogyo Kk コラーゲン産生促進剤、それを含む化粧品、食品および医薬品ならびに皮膚疾患の予防または改善用外用剤
GB0313644D0 (en) * 2003-06-12 2003-07-16 Univ Bristol Inhibition of infection
JP2005289819A (ja) * 2004-03-31 2005-10-20 Nippon Meat Packers Inc 皮膚組織の再生及び肌質改善効果のあるペプチド、並びに該ペプチドを含有する食品、医薬品、又は外用剤
JP4490498B2 (ja) * 2008-09-30 2010-06-23 新田ゼラチン株式会社 疾病抑制剤

Similar Documents

Publication Publication Date Title
US20160136231A1 (en) Topical formulations of chemerin c15 peptides for the treatment of dermatological conditions
JP2016516808A5 (enExample)
HRP20220929T3 (hr) Sastav za inhalaciju koji sadrži aklidinij za liječenje astme
HRP20170358T1 (hr) Inhibitori histonskih demetilaza
JP2009102342A5 (enExample)
HRP20171048T1 (hr) Novi agonisti angiotenzinskog receptora tipa 2 (at2) i njihove upotrebe
EA201291089A1 (ru) Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций
JP2010536745A5 (enExample)
WO2024169972A1 (en) New multi-functional oligopeptides
JP2023526583A (ja) 結核を治療及び抑制するための方法及び組成物
IL265761B1 (en) Oral terlipressin compositions for use in treatment of ascites
JP2023503373A (ja) 新規多機能オリゴペプチド
JP2006527234A5 (enExample)
JP2016517882A5 (enExample)
JP2010514834A5 (enExample)
JP2009506978A5 (enExample)
AU2015287947B2 (en) Compositions for anti-inflammatory, antioxidant effects and improved respiratory function by specific histone deacetylase inhibition
CN116350746B (zh) 沙丁鱼肽组合物在治疗过敏性鼻炎的药物中的应用
CA3254178A1 (en) OPIOID RECEPTOR MODULATOR PHARMACEUTICAL FORMULATIONS
RU2007101538A (ru) Применение фармацевтической композиции, содержащей кальцитриол и пропионат клобетазола, для лечения псориаза
JP2010195714A5 (enExample)
JP2018528259A5 (enExample)
RU2013157398A (ru) Композиция
US20190314325A1 (en) Process and Method to Accelerate Cellular Regeneration, Healing and Wound Management
CN105658202A (zh) 齐留通乳膏剂型的局部用抗炎症药学组合物